Home > News > Labopharm reports results for second quarter fiscal 2004
July 28th, 2004
Labopharm reports results for second quarter fiscal 2004
Labopharm Inc. (TSX: DDS) today reported its results for the second quarter of fiscal 2004 ended June 30, 2004. Net loss for the second quarter of fiscal 2004 was $7.1 million, or $0.18 per share, compared with $8.8 million, or $0.28 per share, for the second quarter of fiscal 2003.
Aspen Aerogels, Inc. Schedules Third Quarter 2014 Earnings Release and Conference Call for November 6, 2014 October 17th, 2014
Nanometrics to Announce Third Quarter Financial Results on October 28, 2014 October 8th, 2014
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Arrowhead Reports Fiscal 2014 Third Quarter Financial Results and Provides Update on ARC-520 August 12th, 2014